Paper Details
- Home
- Paper Details
Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.
Author: BrockChristina, DrewesAsbjørn Mohr, GregersenHans, GrønlundDebbie, KroghKlaus, LiaoDonghua, PoulsenJakob Lykke
Original Abstract of the Article :
BACKGROUND: Opioid analgesics inhibit anal sphincter function and contribute to opioid-induced bowel dysfunction (OIBD). However, it is unknown whether the inhibition can be reduced by opioid antagonism with prolonged-release (PR) naloxone and how this compares to laxative treatment. AIMS: To compa...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1007/s10620-017-4784-7
データ提供:米国国立医学図書館(NLM)
Addressing Opioid-Induced Bowel Dysfunction
Opioid analgesics are effective pain relievers, but they can also cause gastrointestinal side effects such as constipation. This research paper investigates the effects of prolonged-release oxycodone/naloxone on anal sphincter function compared to oxycodone plus macrogol 3350. The authors conducted a randomized, double-blind, crossover trial in 20 healthy men. They found that both oxycodone/naloxone and oxycodone plus macrogol reduced sphincter relaxation compared to baseline, but oxycodone/naloxone showed a significantly greater improvement compared to macrogol. These findings suggest that oxycodone/naloxone may be more effective in reducing opioid-induced bowel dysfunction (OIBD) compared to traditional laxative treatment.
Oxycodone/Naloxone - A Potential Solution for OIBD
This study provides evidence that oxycodone/naloxone may be more effective in reducing OIBD compared to conventional laxative therapy. The findings suggest that this combination therapy could be a valuable tool for managing the gastrointestinal side effects of opioid medications.
Navigating the Desert of Opioid Side Effects
Opioid medications can be a valuable tool for managing pain, but it is important to be aware of their potential side effects. This research highlights the need for more effective strategies for managing OIBD. By developing new treatment options and improving our understanding of the underlying mechanisms of OIBD, we can help patients manage their pain effectively while minimizing the risk of unwanted side effects.
Dr. Camel's Conclusion
This research is like a camel caravan carrying a precious cargo of relief across the desert of OIBD. By investigating the effects of oxycodone/naloxone, this study sheds light on a potential new approach for managing opioid-induced bowel dysfunction. It is a reminder that even in the midst of challenging health conditions, there is always hope for new discoveries and improved treatments.
Date :
- Date Completed 2017-11-06
- Date Revised 2019-05-09
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.